Genmab (GMAB) Event Oct. 18, 2022, 12:48 UTC 5 1 comments (99% Neutral) Genmab (GMAB) Announces Clinical Development Update (Form 6-K) Comment Full text
Akouos Inc (the company became a subdivision of the company LIlly (LLY)) (AKUS) Event Oct. 18, 2022, 12:01 UTC 11 1 comments (80% Positive) Akouos, Inc. (AKUS) Announces Business Combination Comment Full text
Mereo BioPharma (MREO) Event Oct. 18, 2022, 11:07 UTC 4 1 comments (80% Positive) Mereo BioPharma (MREO) Announces Clinical Development Update (Form 6-K) Comment Full text
RedHill Biopharma (RDHL) Event Oct. 18, 2022, 11:05 UTC 4 1 comments (99% Neutral) RedHill Biopharma (RDHL) Announces Clinical Development Update (Form 6-K) Comment Full text
9 Meters Biopharma Inc. (NMTR) Event Oct. 18, 2022, 06:20 UTC 93 0 comments 9 Meters Biopharma to Present at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting Comment Full text
KalVista Pharmaceuticals Inc (KALV) Event Oct. 17, 2022, 20:55 UTC 16 1 comments (75% Positive) KALVISTA PHARMACEUTICALS, INC. (KALV) Provides Update on Retire for Planned Transition - Cambridge Comment Full text
MacroGenics Inc (MGNX) Event Oct. 17, 2022, 20:22 UTC 14 1 comments (10% Negative) MACROGENICS, INC. (MGNX) Announces Delay in treatment Trials for certain blood cancers Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Efficacy Assessment Comment Full text
Rubius Therapeutics (company was delisted NASDAQ) (RUBY) Event Oct. 17, 2022, 20:05 UTC 15 1 comments (99% Neutral) RUBIUS THERAPEUTICS, INC. (RUBY) Announces Executive Departure Comment Full text
Legend Biotech (LEGN) Event Oct. 17, 2022, 20:02 UTC 5 1 comments (99% Neutral) Legend Biotech (LEGN) Files Form 6-K Comment Full text
Pfizer Inc (PFE) Event Oct. 17, 2022, 19:24 UTC 99 0 comments Pfizer Inc. - Pfizer Analyst and Investor Call to Review RSV Data Presented at ID Week 2022 Comment Full text